$AME

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

Original reporting
Published Aug 26, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
9/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The acquisition is expected to be modestly accretive to 2026 adjusted earnings and adds $350 million of sales, enhancing AMETEK's growth trajectory.

02

Market read

The deal underscores continued consolidation in the industrial instrumentation market and may influence peer valuations.

03

What to watch

Potential antitrust review delays and the need to retain key Indicor talent.

Relevance 9/10Novelty 9/10Timing: today

Background

AMETEK announced the completion of its previously disclosed acquisition of Indicor Instrumentation, a portfolio of mission‑critical instrumentation businesses.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK completed a $5.0 billion cash acquisition of Indicor Instrumentation, adding $350 million of sales and being modestly accretive to 2026 earnings.

Expected impact

Short‑term upside as investors price in the accretive acquisition; medium‑term upside if integration synergies materialize.

Evidence & confidence

A $5 bn cash deal for a mid‑cap industrial group is material; the acquisition is accretive and adds recurring revenue streams.

Market effects

Strengthens the industrial instrumentation segment, pressuring peers to consider similar consolidation.

Boosts US industrial tech stocks; limited immediate effect on overseas competitors.

Adds to the narrative of large‑scale M&A in the industrial sector worldwide.

Counterpoint

The high cash outlay could strain AMETEK's balance sheet if integration costs exceed expectations.

Key entities

  • AMETEK, Inc.

    US‑listed industrial technology provider (NYSE: AME).

  • Indicor Instrumentation

    Portfolio of instrumentation businesses being acquired.

Related articles

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.

$AMEHighAI 9/10

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

$AMEHigh

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,

$AMEMedAI 8/10

AMETEK’s (NYSE:AME) Q2 CY2026: Strong Sales

AMETEK (NYSE:AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year on year, exceeding Wall Street estimates by 4.4%, according to the company. Non-GAAP adjusted EPS was $2.09, up from $1.78 and 4.8% above consensus. Analysts expect full-year EPS of $8.46, up from $7.96.

AMETEK Completes Acquisition of Indicor Instrumentation — alphai